Jonah Rubin
Impact in
- Nephrology top 2%
- Parathyroid Disorders and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
- Co-authors
- Mathew S. Maurer (6 shared papers)Adam Castaño (4 shared papers)Rachelle Morgenstern (1 shared paper)Susheel Kodali (1 shared paper)Nadira Hamid (1 shared paper)Tamim Nazif (1 shared paper)Martin B. Leon (1 shared paper)Rebecca T. Hahn (1 shared paper)
- Journals
- CHEST Journal (5 papers)Critical Care Medicine (2 papers)Amyloid (2 papers)Journal of Cardiac Failure (2 papers)Digestive Diseases and Sciences (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Jonah Rubin
46 papers receiving 1.1k citations
Jonah Rubin's Hit Papers
Peers
Comparison fields: 5 of 75
- Nephrology 189
- Oncology 257
- Cardiology and Cardiovascular Medicine 194
- Molecular Biology 589
- Rheumatology 85
Countries citing papers authored by Jonah Rubin
This map shows the geographic impact of Jonah Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonah Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonah Rubin more than expected).
Fields of papers citing papers by Jonah Rubin
This network shows the impact of papers produced by Jonah Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonah Rubin. The network helps show where Jonah Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonah Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement Hit paper breakdown → | 2017 | 453 |
| 2 | 2020 | 103 | |
| 3 | 1983 | 62 | |
| 4 | 2017 | 51 | |
| 5 | 2016 | 49 | |
| 6 | 2017 | 46 | |
| 7 | 1978 | 44 | |
| 8 | Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine. | 1983 | 42 |
| 9 | VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer. | 1976 | 41 |
| 10 | 2011 | 28 | |
| 11 | 1978 | 28 | |
| 12 | Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole). | 1990 | 27 |
| 13 | 2016 | 21 | |
| 14 | 2014 | 17 | |
| 15 | 2018 | 15 | |
| 16 | Pilot study of PALA and 5-FU in patients with advanced cancer. | 1982 | 14 |
| 17 | 2021 | 11 | |
| 18 | 2022 | 11 | |
| 19 | 2021 | 9 | |
| 20 | 2024 | 8 |
About Jonah Rubin
Jonah Rubin is a scholar working on Oncology, Surgery, Molecular Biology, Epidemiology and Biomedical Engineering, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Mechanical Circulatory Support Devices (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Peptidase Inhibition and Analysis (3 papers), Pancreatitis Pathology and Treatment (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cardiac Arrest and Resuscitation (3 papers). The work is most often cited by research in Nephrology (189 citations), Oncology (257 citations), Cardiology and Cardiovascular Medicine (194 citations), Molecular Biology (589 citations) and Rheumatology (85 citations). Jonah Rubin has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Mathew S. Maurer, Adam Castaño, Rachelle Morgenstern, Susheel Kodali, Nadira Hamid, Tamim Nazif, Martin B. Leon, Rebecca T. Hahn, Albert J. DeLuca and Omar Khalique. Their work appears in journals such as CHEST Journal, Critical Care Medicine, Amyloid, Journal of Cardiac Failure and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.